Why In-Hospital STEMI Mortality Is Nearly Double in Women

Cardiovascular disease remains the leading cause of death globally. Although acute myocardial infarction occurs more frequently in men, STEMI mortality in women presents a far more alarming clinical trajectory. A recent landmark study from the UN Mehta Institute of Cardiology and Research Centre (UNMICRC) in Ahmedabad highlights this stark discrepancy. Specifically, women undergoing primary percutaneous coronary intervention (PCI) experienced nearly twice the rate of major adverse cardiovascular events (MACE) compared to men. Consequently, clinicians must recognize these gender differences to optimize acute coronary care in Indian practice.

The UNMICRC Study: Evaluating Gender-Specific Outcomes

The prospective cohort study evaluated 1,748 consecutive STEMI patients undergoing primary PCI. Among these patients, 1,434 were men and 314 were women. Remarkably, the overall rate of in-hospital MACE—encompassing stroke, heart failure, re-infarction, and all-cause death—reached 11.8% in women versus only 6.6% in men. Furthermore, multivariate analysis confirmed female gender as an independent predictor of in-hospital death. This survival gap proved particularly pronounced in patients younger than 75 years. In this subgroup, women exhibited an adjusted odds ratio of 2.05 for in-hospital mortality. Therefore, the findings challenge the assumption that younger post-PCI patients universally share identical prognoses.

Factors Driving Higher STEMI Mortality in Women

Several distinct clinical and biological factors explain this survival gap. First, women in the cohort presented at an older average age than men. Specifically, their mean age was 60.8 years compared to 54.8 years for men. In addition, female patients carried a significantly higher baseline burden of metabolic comorbidities. For instance, diabetes affected 24.8% of women compared to 13.2% of men. Similarly, hypertension occurred in 33.1% of female patients versus 12.9% of male counterparts. Beyond baseline risk profiles, anatomical differences also play a pivotal role. Women frequently possess smaller epicardial coronary vessels. Additionally, they exhibit a higher prevalence of microvascular dysfunction and plaque erosion rather than traditional plaque rupture. As a result, acute presentations often involve complex physiological compromise.

Atypical Symptoms and Systemic Pre-Hospital Delays

Symptom perception significantly affects clinical timelines. While men typically present with retrosternal chest pain, women frequently manifest diffuse and atypical symptoms. These symptoms include profound fatigue, nausea, epigastric discomfort, and radiating jaw or back pain. Because these signs often mimic non-cardiac ailments, patients and primary physicians may overlook acute ischemia. Consequently, Indian women often experience prolonged pre-hospital delays before seeking emergency care. National data from registries like NORIN-STEMI confirm that women face substantial delays from symptom onset to medical contact. Furthermore, women with acute coronary syndrome receive invasive angiography and primary revascularization at significantly lower rates than men. Hence, delayed reperfusion exacerbates myocardial damage and accelerates cardiogenic complications.

Actionable Strategies for Healthcare Providers in India

Bridging this gender gap requires deliberate shifts in acute triage and long-term surveillance. First, emergency departments must adopt standardized protocols for atypical presentations in women. Clinicians should obtain an urgent 12-lead electrocardiogram and cardiac biomarkers for any high-risk female patient presenting with unexplained dyspnea, extreme lethargy, or upper body discomfort. Second, emergency teams must eliminate door-to-balloon time disparities. Interventional teams should pursue rapid reperfusion regardless of atypical features. Third, physicians must intensify cardiovascular screening during the postmenopausal transition. Postmenopausal hormonal changes rapidly accelerate atherosclerotic risk in Indian women. Therefore, proactive management of dyslipidemia, hypertension, and glycemic control during primary care visits remains indispensable.

Frequently Asked Questions

Q1: Why do women experience worse outcomes after primary PCI for STEMI?

Women often present at an older age with more comorbidities, such as diabetes and hypertension. In addition, delayed symptom recognition, smaller vessel size, and higher rates of microvascular disease contribute to increased complication rates.

Q2: What atypical symptoms should prompt emergency cardiac evaluation in female patients?

Clinicians and patients should remain vigilant for unexplained breathlessness, profound fatigue, nausea, vomiting, dizziness, and discomfort radiating to the back, neck, or jaw, even without overt chest pain.

Q3: How does age affect the gender disparity in STEMI mortality?

Recent studies demonstrate that the excess mortality risk in women is highest among patients younger than 75 years. In older age cohorts, mortality rates tend to converge between men and women due to widespread baseline frailty.

References

1. Heart attacks high in men, mortality higher in women - ETHealthworld
2. Patel I, Vyas P, Natarajan K, et al. The Gender Spectrum of In-hospital Survival Post Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction: Exploring Age-driven Trends. Journal of the Saudi Heart Association. 2024;36(2):121-130.
3. Qamar A, et al. In STEMI, women less likely than men to receive PCI, survive to 1 year in India: Insights from the NORIN-STEMI Registry. JACC: Asia. 2023.